Advertisement
Screener

AbCellera Biologics Inc. (ABCL) Net Margin

AbCellera Biologics Inc. (ABCL) Net Margin

  • 2026-06-30: Net Margin -1368.57%.
  • 2026-03-31: Net Margin -519.12%.
  • 2025-12-31: Net Margin -19.94%.
  • 2025-09-30: Net Margin -637.84%.

Complete source-backed net margin history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-1368.57%
2026-03-31-519.12%
2025-12-31-19.94%
2025-09-30-637.84%
2025-06-30-203.27%
2025-03-31-1077.24%
2024-12-31-677.43%
2024-09-30-785.42%
2024-06-30-504.30%
2024-03-31-407.98%
2023-12-31-513.67%
2023-09-30-433.55%
2023-06-30-303.58%
2023-03-31-328.99%
2022-12-31-138.75%
2022-09-3026.26%
2022-06-30-14.78%
2022-03-3153.25%
2021-12-3143.03%
2021-09-30-388.16%
2021-06-30-8.40%
2021-03-3157.82%
2020-12-3156.28%
2020-09-30-28.77%
2020-06-3059.70%
2020-03-31-44.94%

Annual Net Margin

DateNet Margin
2025-12-31-194.88%
2024-12-31-564.83%
2023-12-31-385.00%
2022-12-3132.66%
2021-12-3140.90%
2020-12-3151.00%
2019-12-31-19.04%

Similar stocks

Stock NameCountryMarket CapPE Ratio
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
Tango Therapeutics, Inc. (TNGX)United States$4.154B-42.53
Organon & Co. (OGN)United States$3.603B17.03
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Indivior Pharmaceuticals, Inc. (INDV)$4.250B14.09
Viking Therapeutics, Inc. (VKTX)United States$4.287B-8.51
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47